Role of pharmacogenetics in the management of inflammatory bowel diseases
- Authors
- A. Ansari
- A. Shetty
- A.B. Hawthorne
- A.G. Fraser
- A.M. Marinaki
- B.A. Chabner
- B.G. Feagan
- B.G. Feagan
- C. Cuffari
- C.M. Onnie
- D. Allorge
- E. Liani
- E. Louis
- E. Louis
- E. Masson
- E. Schaeffeler
- E.Y. Krynetski
- G.T. Ho
- G.T. Ho
- I. Tiede
- J.A. Wessels
- J.F. Colombel
- J.R. Cummings
- K. Dilger
- K.J. Sohn
- K.R. Herrlinger
- M. Krajinovic
- M. Pierik
- M. Schwab
- M. Schwab
- M.G. Rots
- N. Ahsen von
- P. Munkholm
- R.B. Gearry
- R.B. Gearry
- R.J. Farrell
- R.J. Farrell
- S. Ardizzone
- S. Lichtiger
- S. Mascheretti
- S. Mascheretti
- S. Sumi
- S. Vermeire
- S.C. Lindgren
- S.P. Travis
- S.R. Brant
- S.R. Targan
- T. Hlavaty
- U. Hindorf
- U. Potocnik
- V. Dideberg
- W. Reinisch
- W.A. Faubion Jr
- Z. Zelinkova
- Publication date
- 1 January 2007
- Publisher
- 'Springer Science and Business Media LLC'
- Doi
Abstract
Abstract is not available.Similar works
Available Versions
Last time updated on 20/07/2021